VASCADE VASCULAR CLOSURE SYSTEM (VCS)
FDA premarket approval P120016/S021 · decided 2018-03-30
Approval details
- PMA number
- P120016
- Supplement
- S021
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- VASCADE VASCULAR CLOSURE SYSTEM (VCS)
- Generic name
- Device, hemostasis, vascular
- Applicant
- Cardiva Medical, Inc.
- Date received
- 2016-11-04
- Decision date
- 2018-03-30
- Days to decision
- 511 days
- Decision code
- APPR
- Product code
- MGB
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Santa Clara, CA
- Statement
- Approval to expand the indication of the VASCADE VCS to include femoral venous access site closure.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| CATALYST II AND III (K130124) | Cardiva Medical, Inc. | 2013-03-14 |
| CARDIVA CATALYST III SYSTEM WITH PROTAMINE SULFATE (K082930) | Cardiva Medical, Inc. | 2009-02-13 |
| BOOMERANG CATALYST/BOOMERANG CATALYST II SYSTEM (K072297) | Cardiva Medical, Inc. | 2007-09-12 |
| BOOMERANG WIRE /BOOMERANG PLUS WIRE SYSTEM, MODEL# B PLUS WIRE 58L (K070485) | Cardiva Medical, Inc. | 2007-03-22 |
| BOOMERANG CLOSUREWIRE VASCULAR CLOSURE SYSTEM (K051817) | Cardiva Medical, Inc. | 2006-12-06 |
| BOOMERANG WIRE (K061075) | Cardiva Medical, Inc. | 2006-09-01 |
| VASOSTASIS VASCULAR CLOSURE SYSTEM (K041486) | Cardiva Medical, Inc. | 2004-10-22 |